Akeso Printed Ivonescimab plus Ligufalimab as First-Line Therapy for PD-L1-Optimistic Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma at ESMO 2024 By Investing.com
Head-to-Head Section 3 Trial In comparison with Pembrolizumab Initiated HONG KONG, Sept.…
What’s China’s function within the uranium market By Investing.com
Investing.com -- China's rising demand for uranium is shaping the worldwide market…
CNOOC Restricted Efficiently Withstands Tremendous Hurricane “Yagi” By Investing.com
HONG KONG, Sept. 14, 2024 /PRNewswire/ -- CNOOC (NYSE:) Restricted (the "Company",…
Dialogue with CGT Leaders! You Are Invited to Be a part of the “2024 GenScript Biotech Global Forum¢London” to Focus on the Future Collectively By Investing.com
PISCATAWAY, N.J., Sept. 14, 2024 /PRNewswire/ -- The yr 2024 marks a…
Masimo Companions with Qualcomm to Develop Subsequent-Technology Smartwatch Reference Platform for Unique Gear Producers By Investing.com
Complete Platform Combines Masimo (NASDAQ:)'s Trade-leading Biosensing Capabilities with Snapdragon Wearable Platforms…
Pfizer Presents Optimistic Information from Section 2 Examine of Ponsegromab in Sufferers with Most cancers Cachexia By Investing.com
Examine met main endpoint of change from baseline in physique weight for…
Breakthrough Remedy designation for Sanbexin sublingual tablets granted by the US Meals and Drug Administration By Investing.com
NANJING, China, Sept. 14, 2024 /PRNewswire/ -- On September 2, 2024, Simcere…
Black Diamond Therapeutics Presents Actual-World Therapy Practices and Affected person Outcomes in Newly Recognized NSCLC Sufferers with Non-Classical Mutations on the European Society for Medical Oncology (ESM By Investing.com
Therapy information had been analyzed from 3,276 circumstances of sufferers with newly…
Sinopec Wins Greatest Environmental Safety Case on the First Sino-European Company ESG Greatest Apply Convention in Frankfurt By Investing.com
FRANKFURT, Germany, Sept. 13, 2024 /PRNewswire/ -- China Petroleum (OTC:) & Chemical…
CareDx Studies Inducement Grants Below Nasdaq Itemizing Rule 5635(c)(4) By Investing.com
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) “ The Transplant Company™ ” a…
